Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiopathology and Sequelae of COVID-19 Infection
NCT04563676Active, not recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Sep 2020
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoints: 8-hour cortisol level at Day 0 and Thyroid Stimulating Hormone level at Day 0. Started Sep 2020; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04563676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04563676.